Evaluation of anticoagulation and nonsurgical major bleeding in recipients of continuous‐flow left ventricular assist devices

Continuous‐flow left ventricular assist device (LVAD) placement has become a standard of care in advanced heart failure treatment. Bleeding is the most frequently reported adverse event after LVAD implantation and may be increased by antithrombotic agents used for prevention of pump thrombosis. This...

Full description

Saved in:

Bibliographic Details
Published in:	Artificial organs Vol. 43; no. 8; pp. 736 - 744
Main Authors:	Veasey, Tara M., Floroff, Catherine K., Strout, Sara E., McElray, Krista L., Brisco‐Bacik, Meredith A., Cook, Jennifer L., Toole, John M., Craig, Michael L., Van Bakel, Adrian B., Meadows, Holly B., Uber, Walter E.
Format:	Journal Article
Language:	English
Published:	United States Wiley Subscription Services, Inc 01.08.2019
Subjects:	Aged Anticoagulants Anticoagulants - adverse effects Anticoagulants - therapeutic use anticoagulation Bleeding Blood Coagulation - drug effects Congestive heart failure Erythrocytes Female Heart Heart-Assist Devices - adverse effects Hemoglobin Hemorrhage Hemorrhage - etiology Hemorrhage - therapy Humans Implantation Incidence Intracranial Hemorrhages - etiology Intracranial Hemorrhages - therapy left ventricular assist device LVAD Male Middle Aged Renal function Retrospective Studies Thromboembolism Thrombosis Thrombosis - prevention & control Ventricle Ventricular assist devices bleeding left ventricular assist device LVAD anticoagulation
ISSN:	0160-564X, 1525-1594, 1525-1594
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!